Analgesics continued to see good sales over 2019 thanks to the 2018 ban on selling antibiotics without a prescription. As a result, Saudi consumers continued to use more analgesics whenever they experience pain whether it is due to headaches, fever or inflammation as they can no longer buy antibiotics without going to a doctor and getting a prescription.
Topical analgesics/anaesthetic continued to grow sales over 2019 thanks to the extension of Cigalah’s line to include Deep Freeze spray and patches. Previously, only Deep Heat rubs, patches and sprays were available in Saudi Arabia.
Adult ketoprofen and adult naproxen continued to see modest sales in 2019 as consumers continued to prefer adult aspirin and adult acetaminophen. These remain cheaper per unit than adult naproxen and adult ketoprofen.
GSK Consumer Healthcare became the new leader in 2019, with this company being created by the global merger of GlaxoSmithKline with Pfizer. This player benefits from offering the wide range of analgesics brands that were previously represented by GlaxoSmithKline, such as Panadol, Voltaren, Solpadeine and Imigran.
In order to tap into the growth of OTC analgesics over 2019, Reckitt Benckiser Group Plc (RB) via its distributer Cigalah Group launched several Nurofen variants over 2019. These were Nurofen 200mg and 400mg tablets as well as Nurofen for Children 100mg/5ml oral suspension.
Despite the improving sales for analgesics over 2019, the SFDA continues to keep an eagle eye on analgesics to make sure that they meet safety regulations. As a result, the SFDA withdrew Julphar Gulf Pharmaceuticals’ Jusprin 81mg and Profinal Suspension 100mg-5ml (100ml) products from the market due to defects in product quality.
You have no recently viewed reports.
Why not browse through our Featured or Trending Reports to see what we have to offer?
Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Saudi Arabia with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the Analgesics industry in Saudi Arabia, our research will save you time and money while empowering you to make informed, profitable decisions.
The Analgesics in Saudi Arabia market research report includes:
Our market research reports answer questions such as:
Why buy this report?
This industry report originates from Passport, our Consumer Health market research database.